Challenges and opportunities for smaller organisations

Guest Speaker: Dr Jayne Spink

About the Proven Connect model and discussion of the TAR survey results
Starts: May 16, 2024 1:00 pm

|

Ends: 2:00 pm

Guest Speaker: Dr Jayne Spink

|

Translational Research Director & Sonja Lawrence: Head of Business Development

Event Location: Online

00
Days
00
Hours
00
Minutes
00
Seconds

Building on 30 years’ experience of prostate cancer research we combine seed funding, scientific expertise, patient voice and commercial experience to partner with companies with the goal to transform prostate cancer pathways.

Our strategy is focused on building a portfolio of promising companies that could impact prostate cancer, co-investing with venture capital funders and impact investors and connecting these companies to the resources and expert support they need to succeed.